STOCK TITAN
  1. Home
  2. Sec-filings
  3. PSTV
  4. [EFFECT] PLUS THERAPEUTICS, INC. SEC Filing

[EFFECT] PLUS THERAPEUTICS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 13, 2026 5:00 P.M.
Form: S-1
CIK: 0001095981
Company Name: PLUS THERAPEUTICS, INC.
File Number: 333-292637

Source: View Original Filing on SEC EDGAR

Plus Therapeutics Inc

NASDAQ:PSTV

View PSTV Stock Overview →

PSTV Rankings

#7058 Ranked by Market Cap
N/A Ranked by Dividends
#92 Top Loser

PSTV Latest News

Apr 2, 2026
Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives
Mar 31, 2026
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mar 31, 2026
Plus Therapeutics Announces Reverse Stock Split 
Mar 26, 2026
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
Mar 19, 2026
Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%

PSTV Latest SEC Filings

Apr 2, 2026
[8-K] PLUS THERAPEUTICS, INC. Reports Material Event
Apr 1, 2026
[Form 4] PLUS THERAPEUTICS, INC. Insider Trading Activity
Apr 1, 2026
[Form 4] PLUS THERAPEUTICS, INC. Insider Trading Activity
Mar 31, 2026
[ARS] PLUS THERAPEUTICS, INC. SEC Filing
Mar 31, 2026
[DEF 14A] PLUS THERAPEUTICS, INC. Definitive Proxy Statement

PSTV Stock Data

1.07M
6.78M
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
AUSTIN